Page 1011 - Small Animal Internal Medicine, 6th Edition
P. 1011

CHAPTER 55   Clinical Conditions of the Bitch and Queen   983


            often unrewarding because of the refractory nature of the   Exploratory laparotomy with the goal of removal of resid-
            ovarian remnant. In the queen, if ovulation or luteinization   ual ovarian tissue confirms and resolves the problem. The
  VetBooks.ir  is stimulated during behavioral estrus, serum progesterone   identification of residual ovarian tissue is facilitated by the
                                                                 presence of active follicles or resultant corpora lutea. The cli-
            levels >2.0 ng/mL are consistent with adequate coital stimu-
            lation and functional luteal tissue. Serum LH is elevated in
                                                                 of when progesterone is elevated. All visible ovarian tissue
            ovariectomized females; it is only elevated in intact females   nician should schedule the surgical procedure during estrus
            during the 12 to 24 h surge. Serum Anti-Müllerian Hormone   should be removed and evaluated by histopathology. If no
            (AMH) assays are now commercially available, have excel-  visible ovarian tissue is identified, all residual tissue at the
            lent correlation with ORS in postpubertal females, and    ovarian pedicles should be resected and submitted for his-
            will differentiate exogenous estrogen exposure from ORS   topathology. Removal of functional luteal tissue may induce
            (Themmen et al., 2010).                              transient signs of pseudopregnancy in dogs and cats post-
              Ultrasound should be used to support a diagnosis of ORS   operatively. If profound, antiprolactin therapy (cabergoline
            based on history, clinical signs, vaginal cytology, and serum   5 µg/kg q24h to effect) can be offered. Successful removal of
            hormone tests; ultrasound also gives the surgeon guidance   remnant ovarian tissue should result in cessation of clinical
            (Video 55.1). Imaging should begin in a sagittal plane slightly   signs of estrus.
            caudolateral to the kidneys (where remnant ovarian tissue   Medical therapy is often requested by clients not eager
            is expected). Remnant ovarian tissue may be visible only   to permit another surgical procedure. Progestational or
            during the follicular phase (anechoic cystic structures) or   androgenic compounds used to suppress follicular ovarian
            the luteal phase (hypoechoic or isoechoic cystic structures)   activity are not recommended because of undesirable side
            (Fig. 55.38,  C). Ectopic ovarian tissue can be difficult to   effects (mammary neoplasia, diabetes mellitus, undesirable
            locate and image using ultrasonography and often requires   behavior). Immunocontraception or GnRH agonist admin-
            operator expertise. The adrenal glands should be evaluated   istration will offer a viable alternative to laparotomy when
            at the same time for normal size and shape.          perfected and commercially available in the United States.




























             A                                          B

             C                                         0
                             +                         1

                                      +                2
                      +                                3

                              +                        4      FIG 55.38
                                                              Ovarian remnant. (A) Malignant transformation (luteoma) of an
                                                       5      ovarian remnant 8 years postovariohysterectomy. (B) Stump
             RT OVARY                                         pyometra in the bitch resulting from chronic progesterone
                                                       6      exposure. (C) Ultrasonographic image of the ovarian remnant
              +  3.13 cm                                      (cursors) having undergone malignant transformation into a
               +  3.90 cm                              7      luteoma.
   1006   1007   1008   1009   1010   1011   1012   1013   1014   1015   1016